What does an estimated glomerular filtration rate (eGFR) of 155 mL/min/1.73 m² indicate in a white male?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

An eGFR of 155 mL/min/1.73 m² in a White Male Indicates Glomerular Hyperfiltration

An eGFR of 155 mL/min/1.73 m² is significantly elevated and represents glomerular hyperfiltration (GHF), which warrants clinical investigation for underlying pathology rather than reassurance of "excellent kidney function."

Understanding the Context

Normal eGFR values in healthy adults are substantially lower than 155 mL/min/1.73 m². According to meta-analysis data from healthy living kidney donors, mean GFR is approximately 107 mL/min/1.73 m² in young adults and remains constant until age 40, after which it physiologically declines 1. The 95th percentile of eGFR in healthy populations ranges from 94.7 to 146.7 mL/min/1.73 m² 2, meaning your patient's value of 155 exceeds even the upper boundary of normal variation.

Reference intervals for eGFR in healthy volunteers have been established at 63.5-139.2 mL/min/1.73 m² (using Rule's quadratic equation) 3, further confirming that 155 is abnormally elevated.

Clinical Significance of This Finding

Hyperfiltration is Associated with Adverse Outcomes

Glomerular hyperfiltration is not benign. Meta-analysis demonstrates that GHF is significantly associated with:

  • Increased all-cause mortality (HR 1.30; 95% CI 1.18-1.42) 2
  • Incident albuminuria (HR 1.43; 95% CI 1.05-1.93) 2
  • Potential associations with rapid eGFR decline, incident dementia, and non-alcoholic fatty liver disease 2

What Causes Hyperfiltration?

You must investigate for:

  • Diabetes mellitus (early diabetic nephropathy classically presents with hyperfiltration)
  • Obesity (increased metabolic demand drives glomerular hyperfiltration)
  • High protein intake (dietary protein load increases GFR)
  • Pregnancy (physiologic hyperfiltration occurs)
  • Single kidney or reduced nephron mass (compensatory hyperfiltration)
  • Hypertension (early adaptive response)
  • Sickle cell disease

Practical Clinical Approach

Immediate Actions:

  1. Verify the measurement: Repeat eGFR and check which equation was used (CKD-EPI 2021 race-free equation is now standard 4)

  2. Assess for measurement error: Consider if the patient has unusually low muscle mass, which could falsely elevate creatinine-based eGFR. If suspected, obtain cystatin C-based eGFR for confirmation 5

  3. Screen for underlying conditions:

    • Hemoglobin A1c and fasting glucose (diabetes screening)
    • Urinalysis with albumin-to-creatinine ratio (check for albuminuria)
    • Blood pressure measurement
    • BMI calculation
    • Dietary history focusing on protein intake
  4. Monitor longitudinally: A single elevated value requires follow-up. Persistent hyperfiltration (>120 mL/min/1.73 m²) over 3-6 months confirms the diagnosis 2

Important Caveats:

  • Do not dismiss this as "super healthy kidneys"—the evidence clearly shows hyperfiltration predicts worse outcomes
  • Age matters: While GFR naturally declines with age starting around 40 years 6, 1, hyperfiltration at any age is pathologic
  • The current KDIGO classification system (G1-G5) does not specifically address hyperfiltration 7, but this represents a gap in the guidelines rather than evidence that it's unimportant

If Hyperfiltration is Confirmed:

  • Address modifiable risk factors (weight loss if obese, glycemic control if diabetic, dietary protein restriction if excessive)
  • Establish baseline albuminuria status
  • Monitor eGFR trajectory every 6-12 months to detect early decline
  • Consider nephrology referral if associated with albuminuria or rapid progression

The key message: An eGFR of 155 mL/min/1.73 m² is abnormal, not optimal, and requires diagnostic evaluation and ongoing monitoring to prevent future kidney disease progression and associated mortality risk.

Related Questions

What is the clinical significance of an estimated glomerular filtration rate of 72 mL/min/1.73 m² in a 42‑year‑old female and what follow‑up is recommended?
What are the normal fluctuations in glomerular filtration rate (GFR) in a healthy adult?
What does an eGFR (estimated Glomerular Filtration Rate) greater than 60 indicate?
What is the estimated glomerular filtration rate (eGFR) for a 69‑year‑old male?
What does a glomerular filtration rate (GFR) of 90 mL/min/1.73 m² indicate?
What airborne infection‑control precautions should be applied to a patient with untreated latent tuberculosis, a persistently positive interferon‑γ release assay, incomplete prior therapy, and who is housed in a congregate detoxification unit where close contacts cannot be identified?
A patient using adaptive servo‑ventilation (ASV) set at 7–15 cm H₂O has an average residual hypopnea index of 6.2 events per hour and is experiencing mask leaks; what management steps should be taken?
What is the maximum recommended oral dose of amitriptyline for adults, and how should the dose be adjusted for elderly patients or those with hepatic impairment?
For an adult with an infected arm graft site, what is the appropriate cefepime dosing regimen?
What treatment recommendations do you suggest for a patient with bipolar II disorder who is currently in a severe depressive episode with panic attacks, taking lamotrigine 300 mg nightly, asenapine 10 mg nightly, and hydroxyzine 10 mg as needed, and who has not responded to aripiprazole 10 mg and brexpiprazole 2 mg?
In a 77-year-old patient with type 2 diabetes who has a urinary tract infection caused by Klebsiella pneumoniae, is cefazolin an appropriate treatment?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.